In Vivo is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Kyowa Pharmaceutical Industry Co. Ltd.

Division of Lupin Ltd.
www.kyowayakuhin.co.jp/en

Latest From Kyowa Pharmaceutical Industry Co. Ltd.

Lupin To Draw On Efficiencies As Japan Pricing Pressures Build

Pricing pressure in Japan is expected to weigh significantly on growth even in the generics segment, putting the focus on manufacturing and R&D efficiencies to sustain progress in this market, according to senior Lupin executives.

Commercial Strategy

Oncology Stakeholders Offer Niche Recommendations To US FDA, But Who Will Ultimately Get Their Way?

Advocates, industry give wish lists for changes to Office of Oncology Excellence, but Commissioner Scott Gottlieb will ultimately determine who gets what.
Drug Review Cancer

2016 Review: Refocus, Reduce, Reform The Watchwords In Japan

While reimbursement pricing issues and policies dominated the Japanese pharma market in 2016, there was also notable commercial activity during the year, although this was more about refocusing and reducing rather than major mergers and acquisitions.

Japan Commercial

2016 Review: Price Pressure Marks A Turbulent Year In Japan

If one theme dominated the Japanese pharma market in 2016 it was reimbursement pricing, with the regular price cuts in April being followed by political pressure over high-priced oncology drugs, and then major new reforms by the end of the year.

Japan Policy
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Cardiovascular
  • Gastrointestinal
  • Immune Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • Lupin Ltd.
  • Senior Management
  • Ray Tsunoda, Pres.
  • Contact Info
  • Kyowa Pharmaceutical Industry Co. Ltd.
    Phone: (81)
    5-13-9 Nishinakajima
    Yodogawa-ku
    Osaka, 532-0011
    Japan
Advertisement
Advertisement
UsernamePublicRestriction

Register